{"schema_version":"secwatch.filing_event.v1","accession":"0001698530-24-000088","form_type":"8-K","ticker":"XCUR","cik":"0001698530","company_name":"EXICURE, INC.","filed_at":"2024-08-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.152430+00:00","generated_at":"2026-05-31T09:45:01.281762+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Exicure Q2 2024 net loss $0.6M; cash only $0.5M, warns of insufficient funding and going concern","bullets":["Cash and cash equivalents $0.5M at June 30, 2024, down from $0.8M at Dec 31, 2023.","Net loss improved to $0.6M from $5.8M in Q2 2023, driven by cost cutting and $0.6M other income from product sample sales.","Management states cash insufficient to fund operations; substantial additional financing needed in the very near term.","Company halted all R&D in Sept 2022 and continues exploring strategic alternatives to maximize stockholder value."],"urls":{"canonical":"https://secwatch.observer/filing/0001698530-24-000088","json":"https://secwatch.observer/filing/0001698530-24-000088.json","markdown":"https://secwatch.observer/filing/0001698530-24-000088.md","text":"https://secwatch.observer/filing/0001698530-24-000088.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1698530/000169853024000088/0001698530-24-000088-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1698530/000169853024000088/xcur-20240813.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T09:45:01.281762+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}